Evidence map›Paper›PMID 25332713›Full record

ArticleJournal of biomedical research2014

Molecular docking studies of anti-cancerous candidates in Hippophae rhamnoides and Hippophae salicifolia.

Talambedu Usha, Sushil Kumar Middha, Arvind Kumar Goyal, Mahesh Karthik, DA Manoj, Syed Faizan, Peyush Goyal, Hp Prashanth, Veena Pande

Abstract read
In one paragraph

Article in Journal of biomedical research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Computational Approaches: A New Frontier in Cancer Research.Combinatorial chemistry & high throughput screening · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Novel series of 1,2,4-trioxane derivatives as antimalarial agents.Journal of enzyme inhibition and medicinal chemistry · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Talambedu UshaDepartment of Biochemistry and Biotechnology, Maharani Lakshmi Ammanni College For Women, Bangalore, India.
Sushil Kumar MiddhaDepartment of Biotechnology, Bhimtal Campus, Kumaun University, Nainital, India.
Arvind Kumar GoyalBamboo Technology, Bodoland University, Kokrajhar, BTAD, Assam, India.
Mahesh KarthikDepartment of Biotechnology, M S Ramaiah Institute of Technology, Bangalore, Karanataka, India.
DA ManojDepartment of Biotechnology, M S Ramaiah Institute of Technology, Bangalore, Karanataka, India.
Syed FaizanDepartment of Biotechnology, M S Ramaiah Institute of Technology, Bangalore, Karanataka, India.
Peyush GoyalDepartment of Biotechnology, Govt. of India, New Delhi, India.
Hp PrashanthDepartment of Biotechnology, Sapthagiri College of Engineering, Bangalore, India.
Veena PandeDepartment of Biotechnology, Bhimtal Campus, Kumaun University, Nainital, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinorhizal plants contain numerous antioxidants that may play a crucial role in preventing the formation of tumors. H-Ras p21, a member of the Ras-GTPase family, is a promising target to treat various kinds of cancers. An in silico docking study was carried out to identify the inhibitory potential of compounds of these plants against H-Ras by using Discovery Studio 3.5 and by using Autodock 4.2. Docking studies revealed that four compounds, isorhamnetin-7-rhamnoside, quercetin-3-glucoside-7-rhamnoside (present in H. rhamnoides), zeaxanthin, and translutein (present in H. salicifolia) significantly bind with binding energies -17.1534, -14.7936, -10.2105 and -17.2217 Kcal/mol, respectively, even though they slightly deviate from Lipinski's rule. Absorption, distribution, metabolism, excretion and toxicity (ADME/tox) analyses of these compounds and their stereoisomers showed that they were less toxic and non-mutagenic. Amongst them, isorhamntein-7-rhamnoside showed hepatotoxicity. Hence, these compounds can be further investigated in vivo to optimize their formulation and concentration and to develop potential chemical entities for the prevention and treatment of cancers.

Indexed as

cancerDiscovery Studio 3.5dockingHippophaeH-RasH. rhamnoidesH. salicifolia

Identifiers

PMID25332713
PMCPMC4197392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.